Evidence map›Paper›PMID 23913596›Full record

ArticleGenesis (New York, N.Y. : 2000)2013

Analysis of primitive erythroid cell proliferation and enucleation using a cyan fluorescent reporter in transgenic mice.

Andrei M Vacaru, Joan Isern, Stuart T Fraser, Margaret H Baron

Open access · greenAbstract read
In one paragraph

Article in Genesis (New York, N.Y. : 2000), 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.2field-weighted citation impact, top 44% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Review
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Andrei M VacaruDepartment of Medicine, The Icahn School of Medicine at Mount Sinai, New York, New York; The Tisch Cancer Institute, The Icahn School of Medicine at Mount Sinai, New York, New York.
Joan Isern
Stuart T Fraser
Margaret H Baron
Tisch Hospital · USIcahn School of Medicine at Mount Sinai · US

Funding

Induction and Specification of Hematopoietic MesodermR01HL062248 · NHLBI · MOUNT SINAI SCHOOL OF MEDICINE OF NYU · PI BARON, MARGARET H · 2000 to 2016
$5.5M
INDUCTION OF YOLK SAC HEMATOPOIETIC MESODERM BY BMP-4R01DK052191 · NIDDK · MOUNT SINAI SCHOOL OF MEDICINE OF NYU · PI BARON, MARGARET H · 1997 to 2011
$4.2M
NHLBI NIH HHS R01 HL062248NIDDK NIH HHS R01 DK052191NIDDK NIH HHS R01 DK52191
6 · The paper itself

Abstract

Primitive erythropoiesis is a vital process for mammalian embryonic development. Here we report the generation and characterization of a new transgenic mouse line that expresses a histone H2B-CFP fusion protein in the nuclei of primitive erythroid cells. We demonstrate the potential of this ε-globin-histone H2B-CFP line for multicolor imaging and flow cytometry analysis. The ε-globin-H2B-CFP line was used to analyze the cell cycle distribution and proliferation of CFP-expressing primitive erythroblasts from E8.5-E13.5. We also evaluated phagocytosis of extruded CFP-positive nuclei by macrophages in fetal liver and placenta. The ε-globin-H2B-CFP transgenic mouse line adds to the available tools for studying the development of the primitive erythroid lineage.

Indexed as

ErythropoiesisAnimalsCell LineageCell NucleusCell ProliferationEmbryo, Mammalianepsilon-GlobinsErythroblastsGenes, ReporterGenotypeGreen Fluorescent ProteinsHistonesMiceMice, TransgenicPhagocytosisRecombinant Fusion ProteinsCyan Fluorescent Proteinepsilon-GlobinsGreen Fluorescent ProteinsHistonesRecombinant Fusion Proteinscyan fluorescent proteinfluorescent reporterhistone fusionimagingprimitive erythropoiesistransgenic mice

Identifiers

PMID23913596
PMCPMC3840118
OpenAlexW1579968991

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.